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ABSTRACT Cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial Cl- channel that is regulated by
protein kinase A and cytosolic nucleotides. Previously, Sheppard and Welsh reported that the sulfonylureas glibenclamide
and tolbutamide reduced CFTR whole cell currents. The aim of this study was to quantify the effects of tolbutamide on CFTR
gating in excised membrane patches containing multiple channels. We chose tolbutamide because weak (i.e., fast-type) open
channel blockers introduce brief events into multichannel recordings that can be readily quantified by current fluctuation
analysis. Inspection of current records revealed that the addition of tolbutamide reduced the apparent single-channel current
amplitude and increased the open-channel noise, as expected for a fast-type open channel blocker. The apparent decrease
in unitary current amplitude provides a measure of open probability within a burst (PO Burst) and the resulting concentration-
response relationship was described by a simple Michaelis-Menten inhibition function. The concentration of tolbutamide
causing a 50% reduction of P0 Burst (540 ± 20 p,M) was similar to the concentration producing a 50% inhibition of short-circuit
current across T84 colonic epithelial cell monolayers (400 ± 20 ,uM). Changes in CFTR gating were then quantified by
analyzing current fluctuations. Tolbutamide caused a high-frequency Lorentzian (corner frequency, fc > 300 Hz) to appear in
the power density spectrum. The fc of this Lorentzian component increased as a linear function of tolbutamide concentration,
as expected for a pseudo-first-order open-blocked mechanism and yielded estimates of the on rate (kon = 2.8 ± 0.3 ,uM-1
s-1), the off rate (koff = 1210 ± 225 s-1), and the dissociation constant (KD = 430 + 80 ,uM). Based on these observations,
we propose that there is a bimolecular interaction between tolbutamide and CFTR, causing open channel blockade.
INTRODUCTION
Cystic fibrosis transmembrane conductance regulator
(CFTR) is an ATP-regulated Cl- channel and a member of
the ATP-binding cassette (ABC) superfamily of proteins. It
was recently reported that the sulfonylurea receptor (SUR)
that regulates ATP-sensitive K+ channels (KATP) is a mem-
ber of this same superfamily of proteins (Aguilar-Bryan et
al., 1995; Inagaki et al., 1995). CFTR Cl- channels are
present in the apical membranes of pancreatic, intestinal,
and airway epithelial cells, where there are known defects in
cAMP-regulated anion and fluid secretion in cystic fibrosis
(CF) (Gray et al., 1988; Tabcharani et al., 1990; Quinton,
1990). CFTR-like channels have also been identified in the
myocardium (Bahinski et al., 1989; Ehara and Ishihara,
1990; Nagel et al., 1992). These cardiac Cl- channels are
thought to accelerate repolarization during the cardiac ac-
tion potential but have an uncertain relationship to CF
(Bahinski et al., 1989). Given the diversity of locations at
which CFTR resides, the pharmacology of this ion channel
has wide clinical implications.
Sulfonylureas are potent blockers of SUR/KATP in
pancreatic islet cells, myocardium, and smooth muscle
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(Ashcroft and Ashcroft, 1992; Edwards and Weston,
1993). Previously, Sheppard and Welsh (1992) reported
that the sulfonylureas tolbutamide and glibenclamide re-
duced CFTR CF- current, as measured by the whole-cell
configuration of the patch-clamp technique. The Ki of
tolbutamide for inhibition of CF- current was estimated
to be 150 ,uM with modest negative cooperativity (Hill
coefficient = 0.8). Although tolbutamide alters the gat-
ing of KATP channels by binding to SUR, these drugs are
also known to affect the activity of intracellular enzymes,
including protein kinase A (Okuno et al., 1988; Caro,
1990; Edwards and Weston, 1993). Thus, there is some
uncertainty regarding the molecular mechanism mediat-
ing the tolbutamide-induced reduction in whole-cell cur-
rent. Understanding the mechanism by which tolbut-
amide reduces ion transport may lead to new insights
regarding the molecular biophysics of CFTR, including
the states of particular domains that participate in gating
(e.g., the required phosphorylation state of the protein,
requirements for concurrent presence of nucleotides) and
the identification of the kinetic state that is most affected.
Based upon these observations, comparisons could then
be made regarding the relationship of CFTR to other
ATP-sensitive channels. Therefore, we decided to iden-
tify and quantify possible sulfonylurea-CFTR interac-
tions in excised membrane patches.
Because most excised membrane patches from CFTR-
transfected L cells contain multiple channels (Venglarik et
al., 1994b; Schultz et al., 1995b), there are two advantages
that favor the use of a weak blocker (i.e., tolbutamide) for
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kinetic analysis. First, a weak open-channel blocker will
cause an apparent reduction in single-channel current am-
plitude due to the effect of the low-pass filter (Miller, 1982).
The normalized unitary current amplitude provides a mea-
sure of the blocker-induced reduction in open probability
within a burst (PO Burst) that is independent of the number of
active channels and the initial P.. Second, weak open-
channel blockers are favored in current fluctuation analysis
because they introduce high-frequency Lorentzian compo-
nents that can be clearly distinguished in the power density
spectra (PDS) (Li and Lindemann, 1983; Van Driessche and
Van Deynse, 1990; Venglarik et al., 1994b). Thus, the
objective of this study was to identify and quantify possible
effects of tolbutamide on CFTR gating in excised mem-
brane patches containing multiple CFTlR channels. The data
presented in this report show that tolbutamide caused a
fast-type open channel blockade of CFTR channels. Some
of our results have been reported previously in abstract form
(Venglarik et al., 1993a, 1994a).
MATERIALS AND METHODS
Cell culture
T84 human colonic epithelial cells were studied between passages 36 and
76. These cells were maintained in a 1:1 mixture of Dulbecco's modified
Eagle's medium and Ham's F12 medium, supplemented with 14 mM
HEPES and 10% calf bovine serum as previously described (Dharmsatha-
phom et al., 1985; Mandel et al., 1986). Unless otherwise specified, all
media and reagents were obtained from Sigma Chemical Co. (St. Louis,
MO). T84 cells were grown to confluence, dispersed with 0.05% trypsin
(Gibco, Grand Island, NY) in a Ca2+- and Mg2+-free phosphate-buffered
saline containing1 mM EDTA, and plated 1:1 on 30-mm Millicell-HA
filters (Millipore, Bedford, MA). The resulting monolayers were used for
Ussing chamber experiments 2-3 weeks after passage.
Mouse L cells transfected with human CFTR (passages 11-60) were
maintained in Dulbecco's modified Eagle's medium (Gibco) containing
10% fetal bovine serum (HyClone, Logan, UT) as described previously
(Yang et al., 1993; Venglarik et al., 1994b). Cells were grown to 90%
confluence, dispersed with Ca2+ - and Mg2+-free phosphate-buffered saline
containing1 mM EDTA, and plated onto collagen-coated plastic coverslips
for patch-clamp studies.
Transepithelial voltage clamp measurements
Filters containing confluent T84 cell monolayers were cut from the plastic
rings and mounted in Ussing chambers (area = 0.5cm2) with a small
quantity of silicone grease. The water-jacketed Ussing chambers were
similar to those used previously to study ion transport across rat colon
(Bridges et al., 1983). The temperature was maintained at37°C, and the
solutions in both compartments were stirred and gassed with air. The
bathing solutions contained (in mM): 120 NaCl, 4.5 KCl,1 CaC12, 1
MgCl2, 10 D-glucose, 10 HEPES-NaOH (pH 7.4). Short-circuit current
(ISC) measurements were obtained with a voltage clamp (model 616C;
University of Iowa Department of Bioengineering) as described previously
(Venglarik and Dawson, 1986). Based on unidirectional tracer fluxes, the
cyclic AMP-stimulated'Sc across T84 colonic monolayers is due to netCl-
secretion (Dharmsathaphorn et al., 1985) and provides an indirect measure
of CFIR activity (Mandel et al., 1986; Tabcharani et al., 1990). Forskolin
(10,M) was used to increase cellular cyclic AMP levels (Bridges et al.,
1983)and was added as a small volume of a 10 mM stock solution in
DMSO. Because tolbutamide is a weak acid, 100 mM stock solutions
contained 0.1 N NaOH to neutralize the pH.
Patch-clamp methodology
Excised inside-out membrane patches were obtained as previously
described (Venglarik et al., 1994b). Briefly, coverslips containing L
cells were transferred to a heated chamber (35-37°C) on the stage of an
inverted microscope. Pipettes were fabricated from Kimax-51 glass
(Kimble), using a two-stage puller (PP-83; Narishige USA, Greenvale,
NY) and had a resistance of 2-5 Mfl when filled with a standard
solution containing (in mM): 150 N-methyl-D-glucamine-HCl, 1 CaCl2,
2 MgCl2, and 10 1,3-bis[tris(hydroxymethyl)-methylamino]propane-
HCI (pH 7.4). Current measurements were obtained with an Axopatch
200A amplifier (Axon Instruments, Sunyvale, CA), which employs a
low-noise integrating headstage. Currents were monitored with a digital
oscilloscope and stored on VHS videotape using pulse code modulation
(model 200; Vetter, Rebersburg, PA). Electrical potentials are reported
with respect to the pipette interior according to the usual convention,
such that positive (i.e., "outward") currents are consistent with in-
creases either in the outward flow of cations from the bath into the
pipette or with the inward flow of anions from the pipette to the bath.
Patches were excised into a solution containing (in mM): 140 NaCl,5
KCl, 2 MgCl2, 10 NaF, 0.5 EGTA, 0.2 CaCl2 and 10 1,3-bis[tris(hy-
droxymethyl)-methylamino]propane-HCl (pH 7.4). F- was included as
a nonspecific inhibitor of phosphatases that might be active on patch
excision and can lead to channel inactivation (Tabcharani et al., 1991),
although we have previously reported that similar outcomes are seen in
the absence of F- (Schultz et al., 1995b, 1996a). The bathing solution
also contained 0.3 mM ATP to maintain CFTR activity (Anderson et al.,
1991; Venglarik et al., 1994b). Cyclic AMP-dependent protein kinase
(PKA) (10 nM; Promega, Madison, WI) was added after excision to
increase CFTR activity (Hwang et al., 1993; Tabcharani et al., 1991).
As previously reported, most CFTR channels remained active for the
duration of patch viability (up to 60 min), despite the fact that the PKA
was washed out in less than 90 s by continuous perfusion (Venglarik et
al., 1994b; Schultz et al., 1995b). Inward current is expected to be
dominated by the flow of Cl- because the pipette did not contain
permeant cations. Thus, CFTR channels were identified by their current
amplitude and by their response to PKA addition.
Kinetic analysis
The digitized current records were played back, low-pass filtered with
an 8-pole Bessel filter (902LPF, Frequency Devices, Haverhill, MA),
and acquired with a TL-1 DMA interface, pClamp software (version
5.5.1; Axon Instruments, Foster City, CA) and an IBM-compatible
486-DX computer. The length of recording, filter cutoff, frequency and
acquisition rate were dependent on the type of analysis being performed
(see below). The pClamp files were analyzed using BioPatch software
(version 3.21; Molecular Kinetics, Pullman, WA). All figures were
constructed using SigmaPlot software (version 5.0; Jandel Scientific,
San Rafael, CA).
Two types of analyses were performed. First, we measured the mean
amplitude of control(icontr.) and fast-blocked channels(Oblo,k) from am-
plitude histograms as described previously (Venglarik et al., 1993b). The
ratio ofiblock'icontrol is related to the underlying change in P. Burst for an
open-blocked mechanism (Miller, 1982). Ten to forty seconds of record
was used to construct amplitude histograms. These recordings were heavily
filtered by a low-pass 8-pole Bessel filter (-3 db = 15 Hz) to reduce the
control and blocker-induced noise and resolve the small changes in the
unitary current amplitude. Second, we used spectral analysis to quantify
tolbutamide-induced changes in CFTR gating (for reviews see DeFelice,
1981; Van Driessche and Van Deynse, 1990). Digital files were reacquired
at a sampling rate of 10 kHz while being filtered at 5 kHz. These records
were divided into nonoverlapping segments containing 8192 data points,
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and the PDS was calculated for each block using BioPatch software.
Spectra from each set of blocks (60-174 spectra) were averaged to increase
precision. These data were fit to Lorentzian type functions of the following
form:
Sf = So/(1 + (f/fc)2). (1)
So is the zero frequency asymptote andf, is the corner frequency where
S0 has been decreased by half. Fits were performed in BioPatch. The
corner frequency is related to a set of opening (r+) and closing (r_)
rates:
2 7f, = r+ + r_. (2)
It is important to distinguish between the transition rates and the underlying
chemical rate constants because they are not always equivalent. Lindemann
and Van Driessche (1977) showed that the chemical rate constants for the
open-blocked model can be derived by plotting 2rLc as a function of
blocker concentration and fitting the expected result to the observed
outcome. This approach has since been applied to quantify the rate con-
stants for other models (Li and Lindemann, 1983; Venglarik et al., 1994b;
Schultz et al., 1995b).
RESULTS
Tolbutamide reduced the cyclic AMP-activated
'Sc across T84 colonic epithelial cells
Ussing chamber experiments were performed to provide
support for the hypothesis that tolbutamide blocks CFTR
in intact epithelial tissue, and to gain further insight
regarding the concentration-response relationship. The
data in Fig. 1 show that tolbutamide reduced the forsko-
lin-stimulated ISC across T84 colonic epithelial cell mono-
layers in a concentration-dependent fashion and that the
effect was consistent with a simple Michaelis-Menten
inhibition function. Fig. 1 A illustrates the current record
from a representative experiment. Forskolin (10 ,M) was
added to solutions bathing both faces of the T84 mono-
layer at the time indicated to increase cellular cAMP and
activate Isc. As mentioned previously, the cAMP-stimu-
lated ISC is due to net transepithelial Cl- secretion
(Dharmsathaphorn et al., 1985; Mandel et al., 1986).
Stepwise addition of tolbutamide caused a concentration-
dependent reduction in Isc. Ouabain (100 ,uM) or furo-
semide (200 ,tM; not shown) was added to the serosal
bathing solution to abolish any remaining Cl- current. In
control experiments, forskolin-stimulated ISC was stable,
in that 87 ± 2% of the peak current remained 30 min after
the addition of forskolin (n = 20). The effect of tolbut-
amide was rapidly reversed upon replacement of the
bathing solutions with solutions containing no tolbut-
amide (not shown). Normalized data from Fig. 1 A and
five similar experiments are summarized in Fig. 1 B. The
solid line shows the best fit of a simple Michaelis-Menten
inhibition function (i.e., 1 - [tolbutamide]/(Ki + [tolbu-
tamide])) to these data. Initially, the data were analyzed,
allowing a Hill coefficient to float, and a value of 0.83 ±
0.03 (r = 0.98) was derived. However, because this value
approached 1 (as it did in the analysis of channel inhi-
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FIGURE 1 Effect of tolbutamide on short-circuit current (IS) across a
T84 colonic epithelial cell monolayer. (A) Representative experiment. (B)
Summary of the results from six such experiments. T84 cell monolayers
were mounted in modified Ussing chambers and voltage clamped as
described in Materials and Methods. Forskolin (10 ,M) was added to both
the mucosal and serosal sides to increase intracellular cAMP and to
activate a chloride secretory current. Tolbutamide was then added in
increasing increments, which produced a stepwise decrease in IS.. The
concentrations indicated are the final concentrations of tolbutamide. Sero-
sal ouabain (100 ,uM) was used to abolish the remaining I,C due to CF-
secretion. The normalized concentration response for the change in ISC (B)
was fit to a simple Michaelis-Menten function, using a nonlinear curve-
fitting routine (Statgraphics, STSC). The solid line illustrates the best fit of
the data (K. = 400 + 20 ,uM).
bition in excised patches; see below), further analysis
constrained the Hill coefficient to unity, and a Ki of 400
± 20 ,uM was predicted. Although the interpretation of
these results is confounded by the presence of two mem-
branes in series, the ISc measurements provide evidence
that tolbutamide inhibits CFTR in colonic epithelial cells.
Furthermore, these results provide insight regarding the
range of tolbutamide concentrations for patch-clamp ex-
periments (see below).
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Effect of tolbutamide on CFTR channel activity
Occasionally we obtained single-channel recordings of
CFTR activity in excised membrane patches (n = 3). Fig. 2
illustrates the effect of 200 ,M tolbutamide on a represen-
tative single channel. The CFTR channel in this patch
inactivated immediately upon excision and was reactivated
by brief exposure to 10 nM PKA (not shown). This obser-
vation and the single-channel current amplitude (-0.80 pA
at -80 mV) are the results expected for CFTR. Addition of
tolbutamide reduced the current amplitude and increased the
open-channel noise. This result is suggestive of fast-flickery
open-channel blockade. Similar effects were observed in 17
other experiments involving multichannel patches. The re-
lationship between tolbutamide concentration and open
probability within a burst (P. Burst) as measured by the
change in the unitary current amplitude is described in the
following section. We did not quantify the effect on gating
using event duration analysis because brief events (i.e., <2
A. Control
ms) cannot be properly resolved due to the poor signal-to-
noise ratio. Instead, we derived the transition rates by ana-
lyzing PDS as described in a subsequent section.
Tolbutamide reduces CFTR open probability
The apparent reduction in unitary current amplitude caused
by a fast open-channel blocker is directly related to the
underlying change in channel open probability within a
burst (PO Burst) (Miller, 1982). Therefore we measured uni-
tary currents of heavily filtered records (-3 db at 15 Hz)
with amplitude histograms. This cutoff frequency was
needed to resolve changes in the small current amplitude
and virtually eliminated the background and blocker-in-
duced noise (not shown). Fig. 3 summarizes these data and
shows that the normalized decrease in CFTR amplitude
(iblocklicontrol) was concentration dependent. Furthermore,
the inhibition was well described by a simple Michaelis-
B. Control
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FIGURE 2 Current records illustrating CFTR channel activity before (control) and after the addition of 200 ,lM tolbutamide (A) and the corresponding
amplitude histograms (B). The dashed line indicates the closed state of the channel. Each line contains 5 s of recording, and a total of 15 s is shown before
and after tolbutamide treatment. The amplitude histograms shown in B were constructed from the recordings in A and were fit to Gaussian functions (solid
lines). The 0.4-ml bath was constantly perfused at a rate of 1.2 ml/min and contained 0.3 mM ATP throughout the experiment. Two to three minutes was
allowed to elapse to permit the composition of the bathing solution to become stationary. Conditions: -80 mV; 140 NaCl; bath, 140 N-methyl-D-glucamine-
HCl pipette; cutoff frequency, 300 Hz; sample rate, 1000 Hz. All points were plotted.
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FIGURE 3 Concentration-response relation for tolbutamide inhibition of
open probability within a burst (P. Burst)- Po Burst was calculated as iblck/
icontrol as described in Materials and Methods. These data were derived
from the amplitude histograms of recordings filtered at 15 Hz and acquired
at 250 Hz. Each point represents the mean and SD of at least three
experiments. Unless otherwise shown, SD falls within the area of the
symbol. These data were fit to a simple Michaelis-Menten inhibition
function using a nonlinear curve-fitting routine (Statgraphics, STSC; Ki =
540 + 20 ,uM). The solid line illustrates the best fit to the data set. Because
of the reduction in current amplitude, it was not possible to obtain accurate
estimates of 'block/'control at concentrations of tolbutamide > 1 mM. Ex-
perimental conditions are described in Materials and Methods and in the
legend for Fig. 2.
Menten function (solid line) with a Ki of 540 ± 20 ,uM. The
Hill coefficient was constrained to unity because initial
A.
analysis revealed that it was not different from 1 (0.96 +
0.04; r = 0.99). This result is suggestive of a simple
bimolecular open-blocked mechanism.
Kinetic analysis of the tolbutamide-induced
change in CFTR gating
Spectral analysis was employed to quantify tolbutamide-
induced changes in CFTR gating. PDS calculated from
current records before and after tolbutamide addition are
illustrated in Fig. 4. The solid lines show the best fits of
these spectra to Lorentzian functions. Both spectra are dom-
inated by a single Lorentzian component at frequencies less
than 30 Hz, as described previously (Venglarik et al.,
1994b; Fischer and Machen, 1994; Schultz et al., 1995b).
The control spectra contain an additional Lorentzian com-
ponent (f, = 100 Hz), which has very little power and is
presumably due to the brief closures described by Haws et
al. (1992). Tolbutamide (1 mM) caused a high-frequency
Lorentzian component to appear in the PDS (fk = 650 Hz),
which is the result expected for an open-block mechanism.
At high concentrations of tolbutamide (i.e., .300 ,uM), the
PDS were equally well fit by calculations employing either
two or three Lorentzian components. Therefore all spectra
were fit to two components. It was not possible to clearly
resolve the blocker-induced Lorentzian component at low
concentrations of tolbutamide (i.e., .200 ,iM) and these
data were excluded from the kinetic analysis (refer to Fig.
5).
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FIGURE 4 Representative power density spectra (PDS) before and after addition of tolbutamide. PDS were constructed as described in Materials and
Methods. Records were filtered at 5 kHz and sampled at 10 kHz. The spectra shown are the average of 87 (control) and 97 (1 mM tolbutamide) spectra.
The solid lines shown in A illustrate the best fit of these data to two Lorentzian components (see Eq. 1) plus a component of frequency-independent noise.
The parameters of the control spectra wereftc = 2.7 Hz, S0o = 2.5 x 10-25 A2Hz,f02 = 100 Hz, S02 = 4.2 X 10-28A2Hz, offset = 6.7 X 10-29A2Hz.
The parameters of the spectra obtained in the presence of tolbutamide werefj = 4.7 Hz, Sol = 7.3 x 10-26A2Hz, f2 = 650 Hz, S02 = 9.0 X 10-28A2Hz,
offset = 1.4 x 10-28A2Hz. Although the increase in the f0 of the low-frequency component was a consistent observation, we did not quantify this result
because of the variance of these data and the possibility of aliasing. This observation is not expected to alter the interpretation of the effects of tolbutamide
on the high-frequency Lorentzian component. (B) Relative contribution of the two Lorentzian components to the PDS in the presence of 1 mM tolbutamide
(solid lines). The corner frequencies (fe) are indicated by the arrows.
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FIGURE 5 The plot of 2iUk as a function of tolbutamide concentration.
Each point represents the mean and SD of at least three experiments that
were analyzed as described in Fig. 4. The solid line was obtained by simple
linear regression of the averaged data. Based on the closed-open-blocked
mechanism, the slope of the line represents the blocker on rate (ko0 = 2.8
0.3 ,lM- s- ), and the intercept is the sum of the blocker off rate (k0ff)
and the closing rate (k,1s0,). Presuming that koff>> kciose, then koff 1210
230 s- l. The ratio of koffko. can be used to calculate the K, (430 ,JM).
The representative spectrum shown in Fig. 4 provides
evidence for the following model:
Closed<->Open<->Blocked
It is possible to construct a more detailed model for CFTR
gating that includes many additional closed states (Haws et
al., 1992; Hwang et al., 1993; Venglarik et al., 1994b;
Schultz et al., 1995b). In the model shown above, the longer
states are grouped together (closed) and infrequent brief
closures are ignored (i.e., bursting = open). This simplifi-
cation is possible because the nucleotide concentration and
phosphorylation status of the channel are constant in these
experiments. Our previous study of CFTR fluctuations un-
der these conditions indicated that the single low-frequency
Lorentzian component (fc 1 to 5 Hz) in the PDS corre-
sponds to the burst duration and interburst interval (Ven-
glarik et al., 1994b). In addition, there is relatively little
power associated with the behavior within a burst in excised
patches (Fisher and Machen, 1994; Schultz et al., 1995b;
also refer to Fig. 4).
We obtained additional support for this simple model and
derived estimates of the kinetic constants by plotting 2irc as
a function of tolbutamide concentration (Fig. 5). A straight
line with a positive slope was fitted to the data, which is the
result expected for an open-blocked transition (Lindemann
and Van Driessche, 1977). Based on rate theory, the slope of
the line corresponds to the on rate (k0n = 2.8 + 0.3 ,uM 1
s- 1), and the ordinate intercept is the sum of the off rate
(k0ff) and the closing rate (kciose) for a closed-open-blocked
mechanism. Assuming that koff>> kciose, then koff 1210
+ 230 s- The ratio of kogkon can be used to calculate the
KD (430 80 ,uM). It is likely that k0ff >> kclose, because
this KD is smaller than the estimate obtained from amplitude
analysis (540 ± 20 ,uM), and the k0ff is substantially greater
than the kciose (6.5 s-1), which we previously reported for
CFTR in these conditions (Venglarik et al., 1994b; Schultz
et al., 1995b). Furthermore, the Ki derived from analysis of
channel activity in excised membrane patches is essentially
the same as the Ki estimated from ISC measurements (400 ±
20 ,uM). As previously stated, the effects of tolbutamide at
the tissue level could result from the sum of interactions at
multiple functional binding sites within the cell. However,
the close agreement with values derived from channels in
excised membrane patches suggests that CFTR is the pri-
mary site of action in the intact tissue.
DISCUSSION
Herein we provide a quantitative description of the interac-
tion between tolbutamide and CFTR in excised membrane
patches. Earlier reports identified the inhibition of chloride
currents by tolbutamide in whole-cell recordings from
CFTR-transfected cells (Sheppard and Welsh, 1992). We
extend this observation by demonstrating that tolbutamide
directly interacts with the open state of CFTR in excised
membrane patches to cause a fast-flickery type of channel
block. Tolbutamide was employed for the present study
because it is a low-affinity ligand that causes a type of block
that can be readily quantified by fluctuation analysis. Our
observations allow us to confirm the relatively low potency
of tolbutamide (KD = 430 ,M) and to determine the chan-
nel state with which tolbutamide interacts.
Glibenclamide, another sulfonylurea, is a more potent
blocker of CFTR chloride channels. Sheppard and Welsh
(1992) reported that glibenclamide was 7 to 8 times as
effective as tolbutamide at inhibiting whole-cell CFTR cur-
rent. Our work has shown that glibenclamide is 10 to 30
times as effective as tolbutamide at blocking CFTR in
excised membrane patches (DeRoos et al., 1993a,b; Schultz
et al., 1996b). The potencies of these sulfonylureas in af-
fecting CFTR closely parallels their relative binding poten-
cies to SUR (Ashcroft and Ashcroft, 1992), suggesting that
the relevant pharmacophore is similar for the two proteins.
Although CFTR and SUR are members of the same protein
family and share characteristics such as nucleotide regula-
tion and sulfonylurea binding, it remains important to note
that the binding affinities for these sulfonylureas are 10,000
times higher for SUR than for CFTR. Thus, the sulfonylu-
rea-binding sites on CFTR and SUR have similarities; how-
ever, a component of the binding site on SUR allows for a
more stable interaction with glibenclamide and tolbutamide.
A second class of sulfonylureas, diaryl-sulfonylureas, ap-
pears to selectively bind to CFTR, thus providing direction
for development of ligands selective for CFTR (Schultz et
al., 1995a).
It has been reported that sulfonylureas interact with a
regulatory protein and not directly with either CFTR (Hon-
gre et al., 1994) or KATP (Ashford et al., 1994). However,
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Aguilar-Bryan et al. (1995) reported that SUR cloned from
HIT T15 cells is, like CFTR, a member of the ABC super-
family of proteins. This parallel between the SUR and
CFTR further supports the hypothesis of a direct ligand-
receptor relationship between the sulfonylureas and CFTR.
Indeed, we have recently shown that the photoactivatable
radiolabeled sulfonylurea, [1251]iodo-glibenclamide, blocks
CFTR channel gating and, when photoactivated, radiolabels
the CFTR protein (Singh et al., 1995).
There is a need to develop selective, high-affinity ligands
for CFTR because no such compounds are available. Sci-
entifically, both openers and blockers would be useful for
definitively resolving the effects of CFTR at the tissue or
organ level. Clinically, compounds of specific interest
would be expected to directly and selectively bind to CFTR
to alter either the trafficking or gating characteristics of
mutant forms of the protein and thus provide relief from
symptoms of the disease. Earlier reports indicated that sul-
fonylureas both permeate the cell membrane (Rabe et al.,
1995) and alter CFTR gating (Sheppard and Welsh, 1992;
Devor et al., 1995), making them candidate compounds for
the development of specific ligands. Our data indicate that
the block of CFTR by tolbutamide is due to a direct inter-
action with the channel protein, because we were able to
show reversible, concentration-dependent effects in excised
patches of cell membrane.
It is important to note that tolbutamide interacts with the
open state of the CFTR channel. In the kinetic schemes that
have been proposed, the open-state conformation is a nu-
cleotide-bound form. It remains unclear whether simple
nucleotide association and dissociation regulate entry to and
exit from the open state or if ATP hydrolytic steps are
required for gating (Schultz et al., 1995b, 1996a; Gunderson
and Kopito, 1995; Hwang et al., 1994). Nonetheless, tolbu-
tamide interacts with the nucleotide-bound, open state of the
channel and precludes it from closing, i.e., tolbutamide
introduces a brief (-800 ,us) nonconducting state of CFTR
that prolongs the duration of the nucleotide-bound form.
Preliminary evidence indicates that AF508-CFTR has a
reduced affinity for ATP that results in a lower likelihood
that it will be in the nucleotide-bound form, which can open
(Schultz et al., 1994a,b). Thus, stabilization of the nucleoti-
de-bound form of the channel has important therapeutic
implications. Future studies will be directed to define com-
pounds which, like tolbutamide, stabilize the open confor-
mation of the channel, but without interrupting ion perme-
ation. Because of the extensive work completed on
sulfonylureas for the treatment of diabetes and bacterial
infections (Ashcroft and Ashcroft, 1992), a wealth of related
compounds are available for further scrutiny. Analysis of
this pharmacopeia will likely provide insights into the
chemical nature of the sulfonylurea-binding site on CFTR
and may result in the identification of therapeutic agents.
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